Arcadia Biosciences, Inc. — Director's Dealing 2018

Jun 9, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2018-06-06

Reporting Person: Comcowich Kevin (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-06	Stock Option (right to buy)	$10.80	A	7476	Acquired	2028-06-06	Common Stock (7476)	Direct

Footnotes

F1: The Option will become 100% vested and excercisable on the earlier to occur of (i) June 6, 2019 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service.